Enriched clinical annotations |
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched. |
Clinical annotation |
Category |
P-value |
Hits |
Hits(%) |
Module hits in category |
Arrays in annotation |
Arrays |
Cancer and cell line (Lung cancer*) |
Lung cancer* |
4.3e-26 |
201 |
20.8 |
964 |
252 |
1945 |
Cancer (Lung cancer*) |
Lung cancer* |
4.3e-26 |
201 |
20.8 |
964 |
252 |
1945 |
Lung tissue, cancer or cell line (Lung cancer*) |
Lung cancer* |
1.6e-23 |
212 |
21.9 |
964 |
276 |
1945 |
Lung cancer (Lung cancer*) |
Lung cancer* |
2.5e-23 |
188 |
19.5 |
964 |
238 |
1945 |
Lung cancer or cell line (Lung cancer*) |
Lung cancer* |
2.5e-23 |
188 |
19.5 |
964 |
238 |
1945 |
Non small cell lung cancer and cell line (Lung cancer*) |
Lung cancer* |
2.4e-21 |
164 |
17.0 |
964 |
205 |
1945 |
Non small cell lung cancer (Lung cancer*) |
Lung cancer* |
2.4e-21 |
164 |
17.0 |
964 |
205 |
1945 |
Liver tissue (Liver cancer*) |
Liver cancer* |
2.0e-18 |
83 |
23.3 |
356 |
187 |
1945 |
Cancer and cell line (Neuro tumors*) |
Neuro tumors* |
9.8e-18 |
79 |
8.1 |
964 |
86 |
1945 |
Cancer (Neuro tumors*) |
Neuro tumors* |
9.8e-18 |
79 |
8.1 |
964 |
86 |
1945 |
Liver tissue, cancer or cell line (Liver cancer*) |
Liver cancer* |
1.1e-16 |
83 |
23.3 |
356 |
197 |
1945 |
Cancer and cell line (Liver cancer) |
Liver cancer |
1.7e-16 |
73 |
94.8 |
77 |
126 |
207 |
CNS cancer or cell line (Neuro tumors*) |
Neuro tumors* |
2.6e-16 |
74 |
7.6 |
964 |
81 |
1945 |
CNS tumor (Neuro tumors*) |
Neuro tumors* |
2.6e-16 |
74 |
7.6 |
964 |
81 |
1945 |
CNS tissue, cancer or cell line (Neuro tumors*) |
Neuro tumors* |
1.9e-15 |
76 |
7.8 |
964 |
85 |
1945 |
Non-tumor liver tissue (Liver cancer) |
Liver cancer |
1.0e-14 |
57 |
67.8 |
84 |
76 |
207 |
Hepatitis infected liver (Liver cancer*) |
Liver cancer* |
1.1e-11 |
63 |
17.6 |
356 |
156 |
1945 |
Prostate (Prostate cancer*) |
Prostate cancer* |
7.1e-11 |
81 |
8.4 |
964 |
101 |
1945 |
Hematologic samples and cell lines (Various tumors) |
Various tumors |
1.4e-09 |
37 |
38.1 |
97 |
37 |
154 |
Hematologic samples (Various tumors) |
Various tumors |
1.4e-09 |
37 |
38.1 |
97 |
37 |
154 |
Cancer (Liver cancer) |
Liver cancer |
2.1e-09 |
63 |
81.8 |
77 |
115 |
207 |
Acute leukemia (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Cancer and cell line (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Cancer (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Hematologic cancer and cell line (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Hematologic cancer (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Hematologic samples and cell lines (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Leukemia (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Leukemia or leukemia cell line (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Monocytes (Leukemia*) |
Leukemia* |
9.9e-09 |
102 |
10.5 |
964 |
141 |
1945 |
Hematologic cancer and cell line (Various tumors) |
Various tumors |
6.9e-08 |
31 |
31.9 |
97 |
31 |
154 |
Hematologic cancer (Various tumors) |
Various tumors |
6.9e-08 |
31 |
31.9 |
97 |
31 |
154 |
Primary blood mononuclear cells (Various tumors) |
Various tumors |
6.9e-08 |
31 |
31.9 |
97 |
31 |
154 |
Diffuse large B cell lymphoma - DLBCL (B lymphoma) |
B lymphoma |
1.1e-07 |
36 |
87.8 |
41 |
126 |
245 |
Cancer and cell line (Various tumors*) |
Various tumors* |
3.0e-07 |
77 |
7.9 |
964 |
105 |
1945 |
Cancer (Various tumors*) |
Various tumors* |
3.0e-07 |
77 |
7.9 |
964 |
105 |
1945 |
Lymphocytes (Various tumors) |
Various tumors |
4.3e-07 |
28 |
28.8 |
97 |
28 |
154 |
Monocytes (Various tumors) |
Various tumors |
4.3e-07 |
28 |
28.8 |
97 |
28 |
154 |
Adenocarcinoma (Liver cancer) |
Liver cancer |
9.2e-07 |
53 |
68.8 |
77 |
97 |
207 |
Diffuse large B cell lymphoma tumor or cell line (B lymphoma) |
B lymphoma |
1.0e-06 |
36 |
87.8 |
41 |
134 |
245 |
Breast tissue or cancer (Breast cancer*) |
Breast cancer* |
1.0e-06 |
43 |
12.0 |
356 |
118 |
1945 |
Female hormonal tissue or cancer (Breast cancer*) |
Breast cancer* |
1.0e-06 |
43 |
12.0 |
356 |
118 |
1945 |
Cell line (NCI60*) |
NCI60* |
1.9e-06 |
93 |
9.6 |
964 |
135 |
1945 |
Hepatocellular carcinoma (Liver cancer) |
Liver cancer |
2.1e-06 |
55 |
71.4 |
77 |
104 |
207 |
Malignant glioblastoma (Neuro tumors) |
Neuro tumors |
2.2e-06 |
6 |
85.7 |
7 |
10 |
90 |
Acute lymphocytic leukemia (Leukemia) |
Leukemia |
4.8e-06 |
85 |
77.2 |
110 |
99 |
149 |
B cells (Various tumors) |
Various tumors |
7.9e-06 |
23 |
23.7 |
97 |
23 |
154 |
Cancer and cell line (NCI60*) |
NCI60* |
8.7e-06 |
93 |
9.6 |
964 |
138 |
1945 |
Epithelial cell line (NCI60) |
NCI60 |
1.0e-05 |
31 |
32.9 |
94 |
32 |
139 |
Breast cancer cell line (Breast cancer) |
Breast cancer |
1.2e-05 |
14 |
28 |
50 |
17 |
152 |
Adenocarcinoma (Breast cancer*) |
Breast cancer* |
1.3e-05 |
39 |
10.9 |
356 |
112 |
1945 |
Breast cancer (Breast cancer*) |
Breast cancer* |
1.3e-05 |
39 |
10.9 |
356 |
112 |
1945 |
Cancer (Breast cancer*) |
Breast cancer* |
1.3e-05 |
39 |
10.9 |
356 |
112 |
1945 |
Female hormonal cancer (Breast cancer*) |
Breast cancer* |
1.3e-05 |
39 |
10.9 |
356 |
112 |
1945 |
Lymphocytes (Leukemia) |
Leukemia |
1.6e-05 |
77 |
75.4 |
102 |
91 |
141 |
Unstimulated immune cells (Stimulated PBMC) |
Stimulated PBMC |
1.8e-05 |
13 |
61.9 |
21 |
39 |
182 |
Cell line (Breast cancer) |
Breast cancer |
2.3e-05 |
20 |
40 |
50 |
30 |
152 |
CNS tissue, cancer or cell line (Various tumors) |
Various tumors |
3.0e-05 |
7 |
70 |
10 |
21 |
154 |
Chronic lymphocytic leukemia (B lymphoma) |
B lymphoma |
3.0e-05 |
29 |
32.9 |
88 |
46 |
245 |
Leukemia (B lymphoma) |
B lymphoma |
3.0e-05 |
29 |
32.9 |
88 |
46 |
245 |
Leukemia or leukemia cell line (B lymphoma) |
B lymphoma |
3.0e-05 |
29 |
32.9 |
88 |
46 |
245 |
Cancer and cell line (Gliomas*) |
Gliomas* |
3.1e-05 |
37 |
3.8 |
964 |
47 |
1945 |
Cancer (Gliomas*) |
Gliomas* |
3.1e-05 |
37 |
3.8 |
964 |
47 |
1945 |
CNS cancer or cell line (Gliomas*) |
Gliomas* |
3.1e-05 |
37 |
3.8 |
964 |
47 |
1945 |
CNS tissue, cancer or cell line (Gliomas*) |
Gliomas* |
3.1e-05 |
37 |
3.8 |
964 |
47 |
1945 |
CNS tumor (Gliomas*) |
Gliomas* |
3.1e-05 |
37 |
3.8 |
964 |
47 |
1945 |
Liver cancer cell line (Liver cancer) |
Liver cancer |
3.4e-05 |
10 |
12.9 |
77 |
10 |
207 |
Lymphoma (Various tumors) |
Various tumors |
4.2e-05 |
20 |
20.6 |
97 |
20 |
154 |
B cells (Leukemia) |
Leukemia |
8.0e-05 |
55 |
53.9 |
102 |
62 |
141 |
Female hormonal tissue, cancer or cell line (Breast cancer*) |
Breast cancer* |
8.1e-05 |
44 |
12.3 |
356 |
141 |
1945 |
Breast tissue, cancer or cell line (Breast cancer*) |
Breast cancer* |
9.8e-05 |
44 |
12.3 |
356 |
142 |
1945 |
Cancer and cell line (Various tumors) |
Various tumors |
0.0001 |
77 |
79.3 |
97 |
105 |
154 |
Cancer (Various tumors) |
Various tumors |
0.0001 |
77 |
79.3 |
97 |
105 |
154 |
Female hormonal cancer cell line (Breast cancer) |
Breast cancer |
0.0001 |
12 |
24 |
50 |
15 |
152 |
Activated B like DLBCL (B lymphoma) |
B lymphoma |
0.0001 |
13 |
31.7 |
41 |
30 |
245 |
Cancer and cell line (NCI60*) |
NCI60* |
0.0002 |
42 |
11.7 |
356 |
138 |
1945 |
Cell line (Liver cancer) |
Liver cancer |
0.0002 |
10 |
12.9 |
77 |
11 |
207 |
Female hormonal cancer or cell line (Breast cancer*) |
Breast cancer* |
0.0003 |
39 |
10.9 |
356 |
127 |
1945 |
Breast cancer or cell line (Breast cancer*) |
Breast cancer* |
0.0003 |
39 |
10.9 |
356 |
128 |
1945 |